Related Experiment Video
Updated: May 25, 2026

06:54
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Simple baseline correction for 1H MRSI data of the prostate
Alan J Wright1, Arend Heerschap
1Department of Radiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. a.wright@rad.umcn.nl
Magnetic Resonance in Medicine
|February 2, 2012
Summary
Proton magnetic resonance spectroscopic imaging aids prostate cancer diagnosis. A new method effectively removes lipid artifacts from spectral data, improving baseline flatness for better tumor detection.
Area of Science:
- Medical Imaging
- Spectroscopy
- Oncology
Background:
- Proton magnetic resonance spectroscopic imaging (sMRI) detects prostate tumors.
- Pattern recognition in sMRI data can differentiate tumor from normal tissue.
- Accurate baseline is crucial for sMRI analysis, but lipid artifacts can interfere.
Purpose of the Study:
- To develop a simple and effective baseline correction method for prostate sMRI.
- To address the challenge of lipid resonances in prostate sMRI data.
- To improve the reliability of sMRI for prostate cancer diagnosis and treatment monitoring.
Main Methods:
- A novel baseline correction technique using subtraction of a single simulated-Lorentzian resonance was proposed.
- Prostate sMRI data acquisition was optimized for a flat baseline with long echo time and water/fat suppression.
- The proposed method was tested on a dataset of prostate sMRI spectra.
Main Results:
- The proposed method successfully restored flat baselines to the test spectra.
- Lipid artifacts, particularly at the prostate margins, were effectively removed.
- The performance of the new method favorably compared to a state-space modeling approach.
Conclusions:
- A simple simulated-Lorentzian resonance subtraction method is effective for baseline correction in prostate sMRI.
- This technique enhances the diagnostic accuracy of sMRI for prostate cancer.
- The method offers a valuable tool for improving prostate cancer detection and treatment monitoring.

